Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Altimol
2. Bt 985
3. Emd 15700
4. Nitrefazol
1. 21721-92-6
2. Altimol
3. 2-methyl-4-nitro-1-(4-nitrophenyl)-1h-imidazole
4. Nitrefazol
5. 2-methyl-4-nitro-1-(4-nitrophenyl)imidazole
6. 1-(4-nitrophenyl)-2-methyl-4-nitroimidazole
7. Bt-985
8. Emd 15 700
9. Emd-15-700
10. Altimol; Emd 15700
11. Vfd629099m
12. 1h-imidazole, 2-methyl-4-nitro-1-(4-nitrophenyl)-
13. Ncgc00183023-01
14. 1h-imidazole, 2-methyl-4-nitro-1-(4-nitrophenyl)- (9ci)
15. Nitrefazol [inn-spanish]
16. Nitrefazolum [inn-latin]
17. Nitrefazolum
18. Einecs 244-542-8
19. Emd 15700
20. Emd-15,700
21. Brn 0546441
22. Nitrefazole [inn:ban]
23. Nitrefazole [mi]
24. Nitrefazole [inn]
25. Dsstox_cid_28752
26. Dsstox_rid_83021
27. Dsstox_gsid_48826
28. Imidazole, 2-methyl-4-nitro-1-(p-nitrophenyl)-
29. Nitrefazole [who-dd]
30. Unii-vfd629099m
31. 1h-imidazole,2-methyl-4-nitro-1-(4-nitrophenyl)-
32. Schembl1606941
33. Chembl1909285
34. Dtxsid2048826
35. Chebi:135009
36. Zinc1842965
37. Tox21_113308
38. Emd-15700
39. Ac-32021
40. Cas-21721-92-6
41. Hy-107030
42. Cs-0027175
43. 5-23-05-00078 (beilstein Handbook Reference)
44. Q27291811
| Molecular Weight | 248.19 g/mol |
|---|---|
| Molecular Formula | C10H8N4O4 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 1 |
| Exact Mass | 248.05455475 g/mol |
| Monoisotopic Mass | 248.05455475 g/mol |
| Topological Polar Surface Area | 110 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 332 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Nitrefazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nitrefazole, including repackagers and relabelers. The FDA regulates Nitrefazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nitrefazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nitrefazole supplier is an individual or a company that provides Nitrefazole active pharmaceutical ingredient (API) or Nitrefazole finished formulations upon request. The Nitrefazole suppliers may include Nitrefazole API manufacturers, exporters, distributors and traders.
Nitrefazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nitrefazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nitrefazole GMP manufacturer or Nitrefazole GMP API supplier for your needs.
A Nitrefazole CoA (Certificate of Analysis) is a formal document that attests to Nitrefazole's compliance with Nitrefazole specifications and serves as a tool for batch-level quality control.
Nitrefazole CoA mostly includes findings from lab analyses of a specific batch. For each Nitrefazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nitrefazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Nitrefazole EP), Nitrefazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nitrefazole USP).
LOOKING FOR A SUPPLIER?
